Results 21 to 30 of about 1,882,529 (345)

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

Frontiers in Neurology, 2020
Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with many neurological symptoms but there is a little evidence-based published material on the neurological ...
Muhammad Hanif, Mukarram Jamat Ali, Danish Kherani   +2 more
exaly   +2 more sources

Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China

Journal of Infection and Public Health, 2023
Background: Accumulating studies demonstrated that patients with coronavirus disease 2019(COVID-19) could develop a variety of neurological manifestations and long-term neurological sequelae, which may be different from the strains.
Xiaolei Shen, Ping Wang, Jun Shen, Yuhan Jiang, Li Wu, Xin Nie, Jianren Liu, Wei Chen   +7 more
doaj   +3 more sources

Neurological Manifestations of Dengue Infection

Frontiers in Cellular and Infection Microbiology, 2017
Dengue counts among the most commonly encountered arboviral diseases, representing the fastest spreading tropical illness in the world. It is prevalent in 128 countries, and each year >2.5 billion people are at risk of dengue virus infection worldwide.
Guo-Hong Li, Zhi-Jie Ning, Yi-Ming Liu, Xiao-Hong Li   +3 more
doaj   +2 more sources

Lifting the mask on neurological manifestations of COVID-19

Nature Reviews Neurology, 2020
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to the respiratory system, and that other organs can be affected.
A. Pezzini, A. Padovani
semanticscholar   +2 more sources

Neurological manifestations in peripartum period [PDF]

Perspectives In Medical Research, 2017
Introduction: Several neurological diseases are unique to pregnancy and postpartum period . Some disorders increase in prevalence during this period. Objective: To study the clinical profile of patients presenting with neurological manifestations in ...
P.Ranjith1 , Meghana Rao2
doaj   +1 more source

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

Journal of Neurological Sciences, 2022
Importance Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system.
Lavienraj Premraj, N. Kannapadi, J. Briggs, Stella Seal, D. Battaglini, J. Fanning, J. Suen, C. Robba, J. Fraser, Sung-Min Cho   +9 more
semanticscholar   +2 more sources

Neurological manifestations of MGUS. [PDF]

Hematology Am Soc Hematol Educ Program
Abstract Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent disorder characterized by a small bone marrow plasma cell or lymphoplasmacytic clone (less than 10%) that produces a small amount of monoclonal paraprotein without associated organ damage. Most patients with MGUS display benign behavior indefinitely,
Cibeira MT, Rodríguez-Lobato LG, Alejaldre A, Fernández de Larrea C.   +3 more
europepmc   +3 more sources

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Cells, 2023
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed “long COVID” or post-acute sequela of COVID-19 (PASC), can implicate persistent neurological complications in up to one ...
Albert Leng, Manuj M. Shah, Syed Ameen Ahmad, Lavienraj Premraj, K. Wildi, G. Li Bassi, C. Pardo, A. Choi, Sung-Min Cho   +8 more
semanticscholar   +1 more source

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

JAMA Network Open, 2021
Key Points Question What are the incidence of and outcomes associated with neurologic manifestations in patients with COVID-19? Findings In this cohort study of 3744 patients in 2 large consortia, neurological manifestations were found in approximately ...
S. Chou, E. Beghi, R. Helbok, E. Moro, J. Sampson, V. Altamirano, Shraddha Mainali, C. Bassetti, J. Suarez, M. McNett   +9 more
semanticscholar   +1 more source

Neurological manifestations of long-COVID syndrome: a narrative review

Therapeutic Advances in Chronic Disease, 2022
Accumulating evidence points toward a very high prevalence of prolonged neurological symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no solidified criteria for ‘long-COVID’ diagnosis.
Maria-Ioanna Stefanou, L. Palaiodimou, E. Bakola, N. Smyrnis, Maria Papadopoulou, G. Paraskevas, E. Rizos, E. Boutati, N. Grigoriadis, C. Krogias, S. Giannopoulos, S. Tsiodras, M. Gaga, G. Tsivgoulis   +13 more
semanticscholar   +1 more source